investing

Best and worst investment ideas for 2016

Biotechnology stocks: Still overvalued
Biotechnology stocks: Still overvalued © iStock

Biotechnology stocks: Still overvalued

The S&P Biotechnology Select Industry Index has plummeted 21% since July 17 but still has more than tripled over the past 5 years. "Biotech stocks are expensive and highly speculative," says Solaris' Ghriskey. That's because many of the medical treatments pursued by biotech companies don't pan out.

"The price of pharmaceuticals remains in the cross hairs of politicians," Ghriskey adds. Several of them have complained about the high prices that biotech and other drug companies are charging for their products. "For the long term, biotech stocks are a great place to be, but in an election year they seem to be a bipartisan punching bag, so there could be headline risk," says BMO's Ablin.

Biotech stocks could be among the first to fall if the overall market tumbles, Ghriskey says. "Given a stock market somewhat constrained by slowing global growth, (coming) increases in interest rates and other issues, I would be cautious of high-valuation names in what remains a very high valuation group," he says. Ghriskey and Ablin say shares of smaller biotech companies are the most dangerous. If you are interested in investing in biotech shares for the long term, wait until after the presidential election, Ablin says.

advertisement

Show Bankrate's community sharing policy
          Connect with us
advertisement
CD & INVESTING NEWSLETTER

Learn the latest trends that will help grow your portfolio, plus tips on investing strategies. Delivered weekly.

CDs and Investment

Can heirs cash an old trust?

Dear Dr. Don, The youngest of 6 children, I am 48 years old. My father joined the Navy at 22. In Italy, he met his bride and my mother, and returned to the U.S. to raise our family. In 1959, he bought a trust certificate... Read more

advertisement

Blog

Dr Don Taylor

Join the accredited investor club

the U.S. House of Representatives voted overwhelmingly (347-8) in early February to approve changing the definition of who is an accredited investor. An accredited investor is qualified to buy exempt securities -- securities not registered with the Securities and Exchange Commission.  ... Read more

Partner Center
advertisement

Connect with us